Featured Research

from universities, journals, and other organizations

Researchers Improve Lung Cancer Survival Rates

Date:
June 24, 2005
Source:
University of Alberta
Summary:
A Canadian national clinical trial has found that chemotherapy following surgery for early-stage non-small cell lung cancer significantly improves survival for the disease over just surgery alone.

A Canadian national clinical trial has found that chemotherapy following surgery for early-stage non-small cell lung cancer significantly improves survival for the disease over just surgery alone.

Related Articles


The research, funded by the Canadian Cancer Society and appearing in tomorrow's issue of the New England Journal of Medicine, is already making an impact around the world.

"With the very significant benefits documented in this study, we are recommending that a brief course of chemotherapy after surgery should be the new standard of care around the world," says Canadian Cancer Society researcher Dr. Timothy Winton, chair of the study and associate professor and director of the Division of Thoracic Surgery at the University of Alberta Hospital in Edmonton.

"In fact, when post-operative chemotherapy was adopted as a standard of care in breast and colon cancer, it was based on data demonstrating much less benefit to what we have now achieved for lung cancer patients," he added.

In the seven-year study involving 482 patients from Canada and the United States, investigators led by Dr. Winton found that post-surgical treatment with the chemotherapy drugs vinorelbine and cisplatin increased the survival rate after five years by 15 per cent. Prior to this research, surgery was the only treatment available for patients with this common type of lung cancer, but the tumour often recurred outside of the lung within a few years and was then incurable.

"Cancer care specialists throughout Canada, the United States, United Kingdom, Scandinavia, Europe, South East Asia and Australia are now giving chemotherapy treatment after surgery to their patients with early-stage non-small cell lung cancer," says Dr. Frances Shepherd, chair of the lung site group committee of the National Cancer Institute of Canada Clinical Trials Group, the organization that coordinated the study. Dr. Shepherd is also a medical oncologist at Princess Margaret Hospital in Toronto and professor of medicine at the University of Toronto.

Lung cancer is one of the most common forms of cancer worldwide, and is the leading cause of death from cancer in North America. Non-small cell lung cancer is the most common type of lung cancer, accounting for more than 80 per cent of all cases. An estimated 22,200 Canadians will be diagnosed with lung cancer this year.

In the study, 242 patients with stage Ib or II non-small cell lung cancer whose tumours had been completely removed received a 16-week course of vinorelbine and cisplatin shortly after surgery. Their outcomes were compared to 240 patients who received surgery alone. In addition to a 15 per cent improvement in the five-year survival rate (69 per cent with chemotherapy versus 54 per cent in the surgery alone group), the rate of cancer recurrence after five years was also significantly reduced--49 per cent in chemotherapy patients versus 61 per cent with patients who received surgery alone.

Among those who did have their cancer relapse, the time between surgery and recurrence was also significantly longer among chemotherapy patients compared to the surgery alone patients.

"These major benefits were achieved with an inexpensive, short period of treatment with limited, short-lived toxic side effects and no major long-term impacts on quality of life," adds Dr. Winton.

Dr. Barbara Whylie, CEO of the Canadian Cancer Society, says "Canadian researchers are breaking through the barriers of what can be achieved in the treatment of lung cancer. Their leadership in this important area will have a significant impact on the lives of people with lung cancer in Canada and around the world. We're delighted to have been a key player in supporting this work."

The lung cancer clinical trial was coordinated by the National Cancer Institute of Canada Clinical Trials Group, which is funded by the Canadian Cancer Society. The Clinical Trials Group is based at Queen's University in Kingston, Ont. With Society funding, the Clinical Trials Group has participated in many groundbreaking trials that have helped change treatment or improve the quality of life for cancer patients worldwide. This research was also supported by the National Cancer Institute in the United States, GlaxoSmithKline and the Canadian Institutes of Health Research.

###

The Canadian Cancer Society is a national community-based organization of volunteers whose mission is to eradicate cancer and to enhance the quality of life of people living with cancer. When you want to know more about cancer, visit our website at www.cancer.ca or call our toll-free, bilingual Cancer Information Service at 1 888 939-3333.


Story Source:

The above story is based on materials provided by University of Alberta. Note: Materials may be edited for content and length.


Cite This Page:

University of Alberta. "Researchers Improve Lung Cancer Survival Rates." ScienceDaily. ScienceDaily, 24 June 2005. <www.sciencedaily.com/releases/2005/06/050622232959.htm>.
University of Alberta. (2005, June 24). Researchers Improve Lung Cancer Survival Rates. ScienceDaily. Retrieved November 24, 2014 from www.sciencedaily.com/releases/2005/06/050622232959.htm
University of Alberta. "Researchers Improve Lung Cancer Survival Rates." ScienceDaily. www.sciencedaily.com/releases/2005/06/050622232959.htm (accessed November 24, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, November 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

AFP (Nov. 23, 2014) The arable district of Kenema in Sierra Leone -- at the centre of the Ebola outbreak in May -- has been under quarantine for three months as the cocoa harvest comes in. Duration: 01:32 Video provided by AFP
Powered by NewsLook.com
Don't Fall For Flu Shot Myths

Don't Fall For Flu Shot Myths

Newsy (Nov. 23, 2014) Misconceptions abound when it comes to your annual flu shot. Medical experts say most people older than 6 months should get the shot. Video provided by Newsy
Powered by NewsLook.com
WFP: Ebola Risks Heightened Among Women Throughout Africa

WFP: Ebola Risks Heightened Among Women Throughout Africa

AFP (Nov. 21, 2014) Having children has always been a frightening prospect in Sierra Leone, the world's most dangerous place to give birth, but Ebola has presented an alarming new threat for expectant mothers. Duration: 00:37 Video provided by AFP
Powered by NewsLook.com
Could Your Genes Be The Reason You're Single?

Could Your Genes Be The Reason You're Single?

Newsy (Nov. 21, 2014) Researchers in Beijing discovered a gene called 5-HTA1, and carriers are reportedly 20 percent more likely to be single. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins